Compare Cipla with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs FULFORD INDIA - Comparison Results

CIPLA     Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA FULFORD INDIA CIPLA/
FULFORD INDIA
 
P/E (TTM) x 32.0 398.8 8.0% View Chart
P/BV x 4.5 6.2 72.8% View Chart
Dividend Yield % 0.5 0.1 533.7%  

Financials

 CIPLA   FULFORD INDIA
EQUITY SHARE DATA
    CIPLA
Mar-20
FULFORD INDIA
Mar-14
CIPLA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs586942 62.2%   
Low Rs357450 79.3%   
Sales per share (Unadj.) Rs207.0691.4 29.9%  
Earnings per share (Unadj.) Rs18.611.5 162.3%  
Cash flow per share (Unadj.) Rs33.215.4 215.9%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.80.3 295.4%  
Book value per share (Unadj.) Rs195.5380.0 51.4%  
Shares outstanding (eoy) m806.353.90 20,675.6%   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.31.0 226.1%   
Avg P/E ratio x25.360.7 41.7%  
P/CF ratio (eoy) x14.245.3 31.4%  
Price / Book Value ratio x2.41.8 131.6%  
Dividend payout %21.517.4 123.3%   
Avg Mkt Cap Rs m379,9122,714 13,996.2%   
No. of employees `00025.80.4 5,820.9%   
Total wages/salary Rs m30,270505 5,994.1%   
Avg. sales/employee Rs Th6,459.66,073.0 106.4%   
Avg. wages/employee Rs Th1,171.21,137.4 103.0%   
Avg. net profit/employee Rs Th580.2100.7 576.3%   
INCOME DATA
Net Sales Rs m166,9492,696 6,191.5%  
Other income Rs m3,442125 2,744.8%   
Total revenues Rs m170,3912,822 6,038.4%   
Gross profit Rs m32,060-46 -69,094.6%  
Depreciation Rs m11,74715 77,279.6%   
Interest Rs m1,97410 20,774.7%   
Profit before tax Rs m21,78254 40,113.8%   
Minority Interest Rs m-4750-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,31210 65,750.0%   
Profit after tax Rs m14,99545 33,546.3%  
Gross profit margin %19.2-1.7 -1,116.0%  
Effective tax rate %29.017.7 163.9%   
Net profit margin %9.01.7 541.8%  
BALANCE SHEET DATA
Current assets Rs m117,0381,738 6,732.9%   
Current liabilities Rs m43,931545 8,065.2%   
Net working cap to sales %43.844.3 98.9%  
Current ratio x2.73.2 83.5%  
Inventory Days Days9648 197.5%  
Debtors Days Days854 1,976.4%  
Net fixed assets Rs m107,42412 902,721.8%   
Share capital Rs m1,61339 4,134.6%   
"Free" reserves Rs m156,0181,443 10,812.0%   
Net worth Rs m157,6301,482 10,636.3%   
Long term debt Rs m23,6930-   
Total assets Rs m236,6262,077 11,394.3%  
Interest coverage x12.06.7 179.2%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.71.3 54.3%   
Return on assets %7.22.6 274.8%  
Return on equity %9.53.0 315.4%  
Return on capital %12.84.3 298.2%  
Exports to sales %33.00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs m55,175NA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m56,03617 325,790.7%   
Fx outflow Rs m6,764673 1,004.8%   
Net fx Rs m49,272-656 -7,511.4%   
CASH FLOW
From Operations Rs m30,68590 34,093.9%  
From Investments Rs m1,040105 994.6%  
From Financial Activity Rs m-29,488-14 209,136.2%  
Net Cashflow Rs m2,340181 1,296.5%  

Share Holding

Indian Promoters % 16.0 0.0 -  
Foreign collaborators % 20.8 75.0 27.7%  
Indian inst/Mut Fund % 12.2 3.8 321.1%  
FIIs % 23.7 0.1 23,700.0%  
ADR/GDR % 1.1 0.0 -  
Free float % 26.2 21.2 123.6%  
Shareholders   161,166 4,783 3,369.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   NATCO PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare CIPLA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers(Closing)

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Related Views on News

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (3QFY20); Net Profit Up 9.4% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, CIPLA has posted a net profit of Rs 4 bn (up 9.4% YoY). Sales on the other hand came in at Rs 44 bn (up 9.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This...(Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun(Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

The Dilemma of Investing in Bharti Airtel(Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Apr 13, 2021 (Close)

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS